Vaccines
Vaccinations
Vaccine Production
Cancer Vaccines
Microorganisms in Medicine and Therapeutics
Cross-reactivity
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 4, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
1Department of Immunology and Infectious Diseases, Johns Hopkins School of Hygiene and Infectious Diseases, Baltimore, MD, USA.
Developing an ideal vaccine requires prioritizing safety and efficacy, alongside features like cost-effectiveness and stability. Future research focuses on simplified vaccines that maintain high safety and efficacy standards for global disease control.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: